- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Lilly licenses Xigris rights to new biotech firm
May 23, 2011
J.K. WallEli Lilly and Co. has agreed to license the U.S. marketing rights of its slow-selling sepsis drug Xigris to a newly created
local biotech company called BioCritica that will seek to reinvigorate sales of the medication.
MoreLilly drug to detect Alzheimer’s criticized by consumer group
May 11, 2011
Bloomberg NewsEli Lilly and Co.’s Amyvid, an experimental imaging agent to detect signs of Alzheimer’s disease in the brain,
shouldn’t be approved because of unreliable study results, a consumer-advocacy group said.
MoreFDA OKs new diabetes pill from Lilly, Boehringer
May 2, 2011
IBJ Staff and Associated PressThe Food and Drug Administration says it has approved a new diabetes pill from Boehringer Ingelheim and Eli Lilly for patients
who can't control their blood sugar with older medicines.
MoreDeveloper plans $13M senior-living center in Westfield
April 27, 2011
IBJ StaffCicero-based developer Mainstreet Property Group LLC plans to build a $13.3 million senior health care center in Westfield.
The 65,000-square assisted living facility will employ about 150 people when it opens in 2012.
MoreLilly teams with Medtronic on Parkinson's treatment
April 26, 2011
J.K. WallEli Lilly and Co. plans to use an implantable drug-delivery system made by Medtronic Inc. to precisely target patients'
brains with an experimental drug for Parkinson’s disease.
MoreMuch unknown about new Cook Group CEO
April 22, 2011
Scott OlsonCarl Cook has been tabbed to replace his father, Bill Cook, who died a week ago. But many in the Bloomington business community
know little about him, which reflects the company's strict privacy policy.
MoreLilly shareholders fail to remove anti-takeover measures
April 18, 2011
J.K. WallA proposal that would have weakened Eli Lilly and Co.’s defenses against an unwanted takeover failed to pass Monday
despite a large majority of shareholders voting to remove those barriers for the second straight year.
MoreLilly shares falter after quarterly earnings report
April 18, 2011
J.K. WallEli Lilly and Co.’s first-quarter profit beat the expectations of Wall Street analysts, but its stock price slipped
anyway Monday morning, along with the broader market.
MoreFDA wants further testing of Lilly pancreas drug
April 16, 2011
Associated PressEli Lilly and Co. Inc. said Friday that the FDA has asked the drugmaker to conduct another clinical trial of its proposed
pancreas drug before it resubmits an application to have the drug approved for sale.
MoreIndiana panel OKs criminal checks on medical workers
April 12, 2011
Associated PressPhysicians, dentists, nurses, veterinarians, pharmacists and other medical workers would have to undergo a criminal background
check when applying for a new state license under a bill approved Tuesday by an Indiana House committee.
MoreArcadia in danger of stock exchange delisting
April 11, 2011
Scott OlsonThe Indianapolis-based health care company's stock, which trades on the NYSE Amex Equities exchange, has closed at an average
price of less than 20 cents over a consecutive 30-day trading period, triggering the warning.
MoreAntidepressants linked to narrowed arteries
April 4, 2011
The study included Eli Lilly and Co. drug Cymbalta, which racked up sales of $3.5 billion last year for the Indianapolis-based
drugmaker.
MoreDrugmaker Lilly launches global service program
March 31, 2011
Associated PressEli Lilly and Co. is starting a service program that sends employees around the world to help developing communities and learn
about other cultures, as the drugmaker looks to international markets.
MoreRegulators delay approval of Lilly's Alzheimer’s screen
March 18, 2011
Bloomberg NewsThe Food and Drug Administration said Lilly needs to create a training program to ensure brain scans are interpreted properly.
MoreTrade agency to probe Lilly's infringement claim
March 17, 2011
Bloomberg NewsEli Lilly and Co.’s patent-infringement claim over Hospira Inc.’s generic version of the cancer treatment Gemzar will be investigated
by a U.S. trade agency with the power to block imports of the copycat drug.
MoreLilly's Bydureon falls short of competitor in study
March 3, 2011
Bloomberg NewsBydureon, the diabetes drug being developed by Amylin Pharmaceuticals Inc., Eli Lilly and Co. and Alkermes Inc., didn’t
control the disease better than Novo Nordisk A/S’s Victoza in a study.
MoreUPDATE: Bioanalytical researcher opening lab in Indianapolis
March 1, 2011
Advion BioServices is expected to open the lab at Purdue Research Park in Indianapolis in May with 49 employees. Some of the
workers may come from Eli Lilly and Co., which is moving its drug-discovery bioanalytical operations to Advion as part of
a partnership.
MoreEli Lilly neuroscience chief resigns
February 25, 2011
J.K. WallDavid Bredt, vice president of neuroscience research, has resigned “to pursue other opportunities,” according
to Lilly spokeswoman Judy Kay Moore. Bredt had overseen Lilly’s development of various drugs, including molecules in
late-stage human testing to treat Alzheimer’s and depression.
MoreUPDATE: Lilly settles pollution suit for $337,500
February 24, 2011
Scott OlsonA complaint filed Wednesday by the U.S. government says Lilly's plant on South Harding Street is emitting high levels of acetonitrile
and methanol, considered hazardous air pollutants by the EPA.
MoreRepeated price cuts take glow off Endocyte IPO
February 12, 2011
Greg AndrewsNew investors got in for $6 a share—which is less than the average price paid by prior investors, a regulatory filing
reveals.
MoreLilly takeover provision to be voted on again
February 11, 2011
Scott OlsonThe effort to remove an 80-percent approval threshold for takeover bids against the wishes of Lilly's board is on the agenda
of the company's April 18 annual meeting.
MoreHealth insurers expect hit from reform rule
February 9, 2011
Associated PressMajor health insurers, including WellPoint, say a provision that requires them to spend a certain percentage of the premiums
they collect on care-related costs will eat into earnings this year.
MoreLilly collaboration with outside researchers yields first deal
February 8, 2011
Chris O'MalleyEli Lilly and Co.'s PD2 project attracted 30,000 compounds from researchers in 26 countries. And Lilly scientist Alan Palkowitz
said it's just the first of many such collaborations.
More2010 compensation fell about 20 percent for top Lilly execs
February 4, 2011
J.K. WallCompensation for Eli Lilly and Co.’s top executives fell last year due to a change to its stock award program and as
the company struggled to bring new medicines to market.
MorePotential competitor to Lilly drug shows promise in study
February 2, 2011
IBJ Staff and Bloomberg NewsSanofi-Aventis's experimental diabetes drug lixisenatide, given to volunteer patients once a day, was at least as effective
as Eli Lilly and Co. and Amylin Pharmaceuticals Inc.'s twice-daily medicine Byetta, a study found.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
Can IBJ please stop referring to this property as "Kessler Mansion"? What a ridiculous title for the biggest, bloated, blight in our city. It's not a mansion. At best, it's an ideal site to shoot low-budget porn. Ahhh! Another business use!
Its stories like these that prove that a Ball State diploma is worth less than the paper that its printed on. A real institution of higher learning would have taken care of this long ago. No way should this crap be taught in a SCIENCE class.
It is such a shame that King Ballard has made Indianapolis into Chicago south with all of the rampant corruption.
How many of these 1,259 bills were actually heard and voted on on the floor vs how many were shot down in committee?
When a an arrogant young guy with essentially no experience and no qualifications for the job, was dropped into an Administrator position out of nowhere by his "mentor" in the Mayor's office things seemed fishy. Sometimes things are what they seem.